Meta-analysis of quality of life in patients with cancer treated with antibody-drug conjugates in randomized controlled trials
Jiuda Zhao(Qinghai University), Guoshuang Shen(Qinghai University Affiliated Hospital), Yong‐Hui Zheng(Michigan State University), Zijun Zhu(Qinghai University Affiliated Hospital), Yuanfang Xin(Qinghai University Affiliated Hospital), Dengfeng Ren(Qinghai University Affiliated Hospital), Yaobang Liu(Ningxia Medical University), Xinlan Liu(Yunnan Agricultural University), Yuyao Tang(Qinghai University Affiliated Hospital), Huihui Li(Shanxi Provincial Children's Hospital), Zhen Liu(Peking University), Jinming Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yi Zhao(University of North Carolina at Chapel Hill), Fuxing Zhao(Qinghai University Affiliated Hospital), Miaozhou Wang(Qinghai University Affiliated Hospital), Cheng-Rong Zhang(Qinghai University Affiliated Hospital)
Cited by 1
Related Papers
Induction of Pyroptosis and Its Implications in Cancer Management
|Frontiers in Oncology|2019|274
PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
|Nature Communications|2016|170
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
|Nature Medicine|2024|121
Development of one-step real-time RT-PCR assay for detection and quantitation of peste des petits ruminants virus
|Journal of Virological Methods|2008|92